Document Detail


Effects of μ-opioid receptor modulation on the hippocampal network activity of sharp wave and ripples.
MedLine Citation:
PMID:  23043226     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND AND PURPOSE: Hippocampus-dependent memory involves the activity of sharp wave ripples (SWRs), which are thought to participate in the process of memory consolidation. The hippocampus contains high levels of endogenous opioids and of μ-opioid receptors (MORs). Here, we have assessed the role of MOR agonists in the modulation of SWRs.
EXPERIMENTAL APPROACH: Using recordings of extracellular potentials from the CA1 field of rat hippocampal slices, we examined the pharmacological actions of morphine, DAMGO and fentanyl on SWRs and on network excitability and paired-pulse inhibition.
KEY RESULTS: All three MOR agonists (1 nM-10 μM) significantly increased the amplitude of sharp waves and the occurrence of SWR sequences, but reduced the initiation of episodes of SWRs. Fentanyl was most potent in producing these effects and morphine the least. Interestingly, although SWRs were reduced by relatively high concentrations (≥100 nM) of all agonists, they were significantly enhanced by very low concentrations of morphine (5-10 nM). Morphine and DAMGO at moderate-to-high concentrations increased network excitability and reduced inhibition. Furthermore, DAMGO suppressed inhibition more readily than it increased excitation, whereas morphine suppressed inhibition only at high concentrations. These drug effects were reversed by the MOR antagonists naloxone and CTOP.
CONCLUSIONS AND IMPLICATIONS: We found that the SWRs were significantly modulated by three MOR agonists and that the SWRs were very sensitive to subtle changes in the excitation/inhibition balance induced by MOR agonists. Such modulation might underlie the effects of these agonists on hippocampus-dependent memory.
Authors:
Panagiotis Giannopoulos; Costas Papatheodoropoulos
Related Documents :
12586776 - Contrasting effects of prenyltransferase inhibitors on estrogen-dependent cell cycle pr...
16033996 - Estrogen receptor beta in health and disease.
19476546 - Ginsenoside rg1 protects against 6-ohda-induced neurotoxicity in neuroblastoma sk-n-sh ...
11854436 - Differential response of estrogen receptors alpha and beta to sp500263, a novel potent ...
15793296 - Microglia lacking e prostanoid receptor subtype 2 have enhanced abeta phagocytosis yet ...
22837346 - Effect of aging on norepinephrine-related proliferative response in primary cultured pe...
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  British journal of pharmacology     Volume:  168     ISSN:  1476-5381     ISO Abbreviation:  Br. J. Pharmacol.     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-02-21     Completed Date:  2013-08-14     Revised Date:  2014-03-09    
Medline Journal Info:
Nlm Unique ID:  7502536     Medline TA:  Br J Pharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  1146-64     Citation Subset:  IM    
Copyright Information:
© 2012 The Authors. British Journal of Pharmacology © 2012 The British Pharmacological Society.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Analgesics, Opioid / pharmacology
Animals
CA1 Region, Hippocampal / drug effects*,  physiology
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- / pharmacology
Evoked Potentials / drug effects
Fentanyl / pharmacology
Male
Morphine / pharmacology
Rats
Rats, Wistar
Receptors, Opioid, mu / agonists*,  physiology
Chemical
Reg. No./Substance:
0/Analgesics, Opioid; 0/Receptors, Opioid, mu; 100929-53-1/Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; 76I7G6D29C/Morphine; UF599785JZ/Fentanyl
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Assessment of glutathione levels in model solution and grape ferments supplemented with glutathione-...
Next Document:  Increased Coagulation in Childhood Obesity.